Bio-Rad Laboratories, Inc. Overview
Pro stress-test →Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics, developing instruments, reagents, and diagnostics for research institutions and clinical laboratories. The company operates two complementary segments: Life Science Research, which provides tools for biological discovery, and Clinical Diagnostics, which serves hospitals and clinical labs with testing systems and quality controls.
Strategic Profile
Pro stress-test →Bio-Rad is extending ddPCR systems into oncology, biopharma quality control and cell & gene therapy release testing. The company faces near-term headwinds with anticipated challenges in the biopharma market and among small biotech companies, with ongoing uncertainty in the Chinese market expected to persist into 2026, but maintains strategic focus on acquisitions and margin improvement.
Competitive Landscape
Pro stress-test →Bio-Rad faces intense competition from large multinational corporations including Thermo Fisher Scientific, Danaher, and Abbott Laboratories, which have substantial resources and global reach that could pressure market share and pricing power. The company differentiates through specialized ddPCR technology and diagnostic automation, though competitive intensity in life sciences and diagnostics remains high.
Industry Context
Bio-Rad Laboratories, Inc. operates in Life Sciences Research & Clinical Diagnostics.
Key facts
Founded: 1952 · Headquarters: Hercules, US · Employees: 8,000+ · Revenue: $2.58B · Market cap: $4.45B